Be Patient & the Bottom Line is....... This company was founded in 1996 and has been publicly traded since 2000. BPAX has enough drugs in the pipeline and joint ventures to survive the past set-back. The competition for new drugs is so fierce that the big boys will buy this company before it goes under. The delinquency notice with a future possibility of the delisting process is not even an issue when they're compared to the time frame of future annoucements. Just relax and be patient. The calvary is on the way.
News 
Market Data 
Discover 
